Alumis Inc. Completes Acquisition, Announces Leadership Changes
Ticker: ALMS · Form: 8-K · Filed: May 21, 2025 · CIK: 1847367
| Field | Detail |
|---|---|
| Company | Alumis Inc. (ALMS) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, leadership-change, corporate-action
TL;DR
Alumis Inc. just bought Esker Therapeutics and shook up its board/exec team. Big moves!
AI Summary
Alumis Inc. announced on May 21, 2025, the completion of its acquisition of Esker Therapeutics, Inc. The filing also details the departure of certain officers and directors, the election of new directors, and the appointment of new officers. Additionally, Alumis Inc. reported on compensatory arrangements for its officers.
Why It Matters
This 8-K filing signals significant corporate restructuring and strategic growth for Alumis Inc. through acquisition, alongside changes in its leadership team.
Risk Assessment
Risk Level: medium — The filing involves significant corporate actions like an acquisition and leadership changes, which inherently carry integration and strategic risks.
Key Players & Entities
- Alumis Inc. (company) — Registrant
- Esker Therapeutics, Inc. (company) — Acquired Company
- May 21, 2025 (date) — Report Date
FAQ
What was the exact date of the name change from FL2021-001, Inc. to Alumis Inc.?
The date of the name change from FL2021-001, Inc. was February 22, 2021.
What is Alumis Inc.'s Standard Industrial Classification code?
Alumis Inc.'s Standard Industrial Classification code is 2834, for Pharmaceutical Preparations.
What is the business address of Alumis Inc.?
The business address of Alumis Inc. is 280 East Grand Avenue, South San Francisco, CA 94080.
What is the SEC file number for Alumis Inc.?
The SEC file number for Alumis Inc. is 001-42143.
What is the fiscal year end for Alumis Inc.?
The fiscal year end for Alumis Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding ALUMIS INC. (ALMS).